These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20587590)

  • 1. NF1 inactivation revs up Ras in adult acute myelogenous leukemia.
    Mullally A; Ebert BL
    Clin Cancer Res; 2010 Aug; 16(16):4074-6. PubMed ID: 20587590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF1 inactivation in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Wang Y; Liu Y; Wright W; Roulston D; Purkayastha A; Dressel A; Karp J; Bockenstedt P; Al-Zoubi A; Talpaz M; Kujawski L; Liu Y; Shedden K; Shakhan S; Li C; Erba H; Malek SN
    Clin Cancer Res; 2010 Aug; 16(16):4135-47. PubMed ID: 20505189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia.
    Largaespada DA; Brannan CI; Jenkins NA; Copeland NG
    Nat Genet; 1996 Feb; 12(2):137-43. PubMed ID: 8563750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
    Quesnel B; Preudhomme C; Vanrumbeke M; Vachee A; Lai JL; Fenaux P
    Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts.
    Illmer T; Thiede C; Fredersdorf A; Stadler S; Neubauer A; Ehninger G; Schaich M
    Clin Cancer Res; 2005 May; 11(9):3217-24. PubMed ID: 15867216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
    Side L; Taylor B; Cayouette M; Conner E; Thompson P; Luce M; Shannon K
    N Engl J Med; 1997 Jun; 336(24):1713-20. PubMed ID: 9180088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
    Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B; Bollag G; Shannon K
    Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
    Böhm A; Aichberger KJ; Mayerhofer M; Herrmann H; Florian S; Krauth MT; Derdak S; Samorapoompichit P; Sonneck K; Vales A; Gleixner KV; Pickl WF; Sperr WR; Valent P
    Eur J Clin Invest; 2009 May; 39(5):395-405. PubMed ID: 19320940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity.
    Mangues R; Corral T; Lu S; Symmans WF; Liu L; Pellicer A
    Oncogene; 1998 Oct; 17(13):1705-16. PubMed ID: 9796699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
    Kalra R; Paderanga DC; Olson K; Shannon KM
    Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression analysis of acute myeloid leukemia to understand leukemogenic pathways associated with differentiation inhibition].
    Ichikawa H
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2128-33. PubMed ID: 16411441
    [No Abstract]   [Full Text] [Related]  

  • 18. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
    Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM
    Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
    King D; Yang G; Thompson MA; Hiebert SW
    Oncogene; 2002 Jul; 21(32):4978-82. PubMed ID: 12118376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
    Verhaak RG; Wouters BJ; Erpelinck CA; Abbas S; Beverloo HB; Lugthart S; Löwenberg B; Delwel R; Valk PJ
    Haematologica; 2009 Jan; 94(1):131-4. PubMed ID: 18838472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.